Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 282 Cr.
- Current Price ₹ 270
- High / Low ₹ 367 / 88.2
- Stock P/E 35.6
- Book Value ₹ 60.5
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 4.46 times its book value
- Earnings include an other income of Rs.5.12 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 107 | |
| 98 | |
| Operating Profit | 9 |
| OPM % | 9% |
| 5 | |
| Interest | 2 |
| Depreciation | 1 |
| Profit before tax | 10 |
| Tax % | 23% |
| 8 | |
| EPS in Rs | 7.70 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 94% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Equity Capital | 10 |
| Reserves | 53 |
| 31 | |
| 54 | |
| Total Liabilities | 148 |
| 40 | |
| CWIP | 12 |
| Investments | 1 |
| 95 | |
| Total Assets | 148 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 9 | |
| -30 | |
| 18 | |
| Net Cash Flow | -4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | 70 |
| Inventory Days | 208 |
| Days Payable | 188 |
| Cash Conversion Cycle | 90 |
| Working Capital Days | 62 |
| ROCE % |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Oct - Registrar confirms Regulation 74(5) not applicable; all shares dematted; no rematerialisation requests for quarter ended Sep 30, 2025.
- Closure of Trading Window 27 Sep
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
23 Sep - AGM on Sep 23, 2025: adopted FY2024-25 financials; re‑appointments and independent director appointments approved.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 23 Sep
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
22 Sep - Allotment of 600,000 convertible warrants to promoters via preferential allotment on Sept 16, 2025.
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions